NCT00005674View on ClinicalTrials.gov

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Creatine

Trial Locations (1)

63110

Washington University, St Louis

All Listed Sponsors

collaborator

Muscular Dystrophy Association

OTHER

lead

National Center for Research Resources (NCRR)

NIH